{"id":2638,"date":"2024-10-07T15:45:28","date_gmt":"2024-10-07T13:45:28","guid":{"rendered":"https:\/\/okuvision.de\/news\/leitlinie-rp\/"},"modified":"2026-05-21T13:47:50","modified_gmt":"2026-05-21T11:47:50","slug":"leitlinie-rp","status":"publish","type":"post","link":"https:\/\/okuvision.de\/fr\/news\/leitlinie-rp\/","title":{"rendered":"Directive 045\/23 : \u00c9lectrostimulation dans la RP"},"content":{"rendered":"

[vc_row row_height_percent=\u00a0\u00bb0″ override_padding=\u00a0\u00bbyes\u00a0\u00bb h_padding=\u00a0\u00bb0″ top_padding=\u00a0\u00bb0″ bottom_padding=\u00a0\u00bb0″ back_color=\u00a0\u00bbcolor-206913″ overlay_alpha=\u00a0\u00bb50″ gutter_size=\u00a0\u00bb3″ column_width_percent=\u00a0\u00bb100″ shift_y=\u00a0\u00bb0″ z_index=\u00a0\u00bb0″ content_parallax=\u00a0\u00bb0″ uncode_shortcode_id=\u00a0\u00bb100151″ back_color_type=\u00a0\u00bbuncode-palette\u00a0\u00bb][vc_column width=\u00a0\u00bb1\/1″]\n

\n \n \n
<\/div>\n \n \n
\n \n
\n
\n \n
\n \n Lesedauer ca. 2 Min. <\/span>\n \n 7. octobre 2024 <\/span>\n <\/div>\n \n

\n L'\u00e9lectrostimulation comme option th\u00e9rapeutique <\/h1>\n \n
\n \n <\/div>\n \n
\n Recherche et preuves<\/span>\n Entreprise & R\u00e9seau<\/span>\n Th\u00e9rapie et utilisation<\/span>\n <\/div>\n \n <\/div>\n \n \n
\n \"Okuvision: <\/div>\n <\/div>\n \n <\/div>\n \n<\/div>\n\n\n[\/vc_column][\/vc_row][vc_row row_height_percent=\u00a0\u00bb0″ override_padding=\u00a0\u00bbyes\u00a0\u00bb h_padding=\u00a0\u00bb2″ top_padding=\u00a0\u00bb3″ bottom_padding=\u00a0\u00bb3″ overlay_alpha=\u00a0\u00bb50″ gutter_size=\u00a0\u00bb3″ column_width_percent=\u00a0\u00bb100″ shift_y=\u00a0\u00bb0″ z_index=\u00a0\u00bb0″ content_parallax=\u00a0\u00bb0″ uncode_shortcode_id=\u00a0\u00bb959669″ row_name=\u00a0\u00bbEinleitung\u00a0\u00bb][vc_column column_width_percent=\u00a0\u00bb70″ gutter_size=\u00a0\u00bb3″ overlay_alpha=\u00a0\u00bb50″ shift_x=\u00a0\u00bb0″ shift_y=\u00a0\u00bb0″ shift_y_down=\u00a0\u00bb0″ z_index=\u00a0\u00bb0″ medium_width=\u00a0\u00bb0″ mobile_width=\u00a0\u00bb0″ width=\u00a0\u00bb1\/1″ uncode_shortcode_id=\u00a0\u00bb705359″][vc_custom_heading heading_semantic=\u00a0\u00bbh3″ text_size=\u00a0\u00bbh3″ uncode_shortcode_id=\u00a0\u00bb151058″]L’\u00e9lectrostimulation comme option th\u00e9rapeutique \u2013
\nla directive ophtalmologique actuelle mentionne l’\u00e9lectrostimulation dans la r\u00e9tinite pigmentaire[\/vc_custom_heading][vc_column_text uncode_shortcode_id=\u00a0\u00bb179329″]Dans la r\u00e9vision de leur directive 25 (d\u00e9sormais directive AWMF 045\/23) pour les maladies h\u00e9r\u00e9ditaires de la r\u00e9tine, de la choro\u00efde et des voies visuelles, la Soci\u00e9t\u00e9 allemande d’ophtalmologie (DOG), la Soci\u00e9t\u00e9 de r\u00e9tinologie (RG) et l’Association professionnelle des ophtalmologistes d’Allemagne (BVA) mentionnent l’\u00e9lectrostimulation comme option th\u00e9rapeutique dans la r\u00e9tinite pigmentaire (RP). L’\u00e9tude lanc\u00e9e en mai dans le cadre de la directive d’\u00e9valuation du G-BA est \u00e9galement cit\u00e9e comme contexte d’application possible. <\/p>\n

Gr\u00e2ce \u00e0 la r\u00e9vision de la directive, les ophtalmologistes disposent d\u00e9sormais d’options th\u00e9rapeutiques concr\u00e8tes pour le traitement symptomatique des dystrophies r\u00e9tiniennes h\u00e9r\u00e9ditaires, avec l’\u00e9lectrostimulation dans la RP et la th\u00e9rapie g\u00e9nique dans l’ACL.<\/p>\n

Vous trouverez le texte original de la directive au format PDF en t\u00e9l\u00e9chargement :<\/p>\n

\u2013 sur le site web de la Soci\u00e9t\u00e9 de r\u00e9tinologie<\/strong>
\n<\/a> \u2013 sur le site web de la Soci\u00e9t\u00e9 allemande d’ophtalmologie<\/a><\/strong><\/p>\n

D\u00e9couvrez l’efficacit\u00e9 et la s\u00e9curit\u00e9 de la th\u00e9rapie OkuStim\u00ae<\/p>\n

Vers les donn\u00e9es d’\u00e9tudes TES<\/a><\/strong>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

La DOG, la RG et le BVA mentionnent l’\u00e9lectrostimulation comme option th\u00e9rapeutique dans la r\u00e9tinite pigmentaire et renvoient \u00e0 l’\u00e9tude d’\u00e9valuation du G-BA.<\/p>\n","protected":false},"author":10,"featured_media":1569,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[187,188,190],"tags":[],"class_list":["post-2638","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-recherche-preuves","category-entreprise-reseau","category-therapie-utilisation"],"yoast_head":"\nDirective 045\/23 : \u00c9lectrostimulation recommand\u00e9e dans la RP<\/title>\n<meta name=\"description\" content=\"La DOG, la RG et le BVA mentionnent l'\u00e9lectrostimulation comme option dans la RP (directive 045\/23). Acc\u00e8s au texte de la directive et information sur l'\u00e9tude d'\u00e9valuation du G-BA.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/okuvision.de\/fr\/news\/leitlinie-rp\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Directive 045\/23 : \u00c9lectrostimulation dans la RP\" \/>\n<meta property=\"og:description\" content=\"La DOG, la RG et le BVA mentionnent l'\u00e9lectrostimulation comme option dans la RP (directive 045\/23). Acc\u00e8s au texte de la directive et information sur l'\u00e9tude d'\u00e9valuation du G-BA.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/okuvision.de\/fr\/news\/leitlinie-rp\/\" \/>\n<meta property=\"og:site_name\" content=\"Okuvision\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-07T13:45:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-21T11:47:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/okuvision.de\/wp-content\/uploads\/2021\/10\/AdobeStock_1477380325_sw.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2362\" \/>\n\t<meta property=\"og:image:height\" content=\"1575\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Melanie Broll\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Melanie Broll\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/news\\\/leitlinie-rp\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/news\\\/leitlinie-rp\\\/\"},\"author\":{\"name\":\"Melanie Broll\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/#\\\/schema\\\/person\\\/8c5876ce322b1d535e693245db31cc1b\"},\"headline\":\"Directive 045\\\/23 : \u00c9lectrostimulation dans la RP\",\"datePublished\":\"2024-10-07T13:45:28+00:00\",\"dateModified\":\"2026-05-21T11:47:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/news\\\/leitlinie-rp\\\/\"},\"wordCount\":373,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/news\\\/leitlinie-rp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/okuvision.de\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/AdobeStock_1477380325_sw.png\",\"articleSection\":[\"Recherche et preuves\",\"Entreprise & R\u00e9seau\",\"Th\u00e9rapie et utilisation\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/okuvision.de\\\/fr\\\/news\\\/leitlinie-rp\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/news\\\/leitlinie-rp\\\/\",\"url\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/news\\\/leitlinie-rp\\\/\",\"name\":\"Directive 045\\\/23 : \u00c9lectrostimulation recommand\u00e9e dans la RP\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/news\\\/leitlinie-rp\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/news\\\/leitlinie-rp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/okuvision.de\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/AdobeStock_1477380325_sw.png\",\"datePublished\":\"2024-10-07T13:45:28+00:00\",\"dateModified\":\"2026-05-21T11:47:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/#\\\/schema\\\/person\\\/8c5876ce322b1d535e693245db31cc1b\"},\"description\":\"La DOG, la RG et le BVA mentionnent l'\u00e9lectrostimulation comme option dans la RP (directive 045\\\/23). Acc\u00e8s au texte de la directive et information sur l'\u00e9tude d'\u00e9valuation du G-BA.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/news\\\/leitlinie-rp\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/okuvision.de\\\/fr\\\/news\\\/leitlinie-rp\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/news\\\/leitlinie-rp\\\/#primaryimage\",\"url\":\"https:\\\/\\\/okuvision.de\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/AdobeStock_1477380325_sw.png\",\"contentUrl\":\"https:\\\/\\\/okuvision.de\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/AdobeStock_1477380325_sw.png\",\"width\":2362,\"height\":1575,\"caption\":\"Okuvision: Arztgespr\u00e4ch\u00a0\u2013 H\u00e4nde von Patienten und Arzt auf dem Tisch\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/news\\\/leitlinie-rp\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Directive 045\\\/23 : \u00c9lectrostimulation dans la RP\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/\",\"name\":\"Okuvision\",\"description\":\"\u2013 Sehen erhalten\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/#\\\/schema\\\/person\\\/8c5876ce322b1d535e693245db31cc1b\",\"name\":\"Melanie Broll\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ac571fa56fb7caf06fa0a3b99fbe83e949790cb8ce1b8cf70eba98e70e26bd7a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ac571fa56fb7caf06fa0a3b99fbe83e949790cb8ce1b8cf70eba98e70e26bd7a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ac571fa56fb7caf06fa0a3b99fbe83e949790cb8ce1b8cf70eba98e70e26bd7a?s=96&d=mm&r=g\",\"caption\":\"Melanie Broll\"},\"url\":\"https:\\\/\\\/okuvision.de\\\/fr\\\/news\\\/author\\\/melanie-broll\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Directive 045\/23 : \u00c9lectrostimulation recommand\u00e9e dans la RP","description":"La DOG, la RG et le BVA mentionnent l'\u00e9lectrostimulation comme option dans la RP (directive 045\/23). Acc\u00e8s au texte de la directive et information sur l'\u00e9tude d'\u00e9valuation du G-BA.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/okuvision.de\/fr\/news\/leitlinie-rp\/","og_locale":"fr_FR","og_type":"article","og_title":"Directive 045\/23 : \u00c9lectrostimulation dans la RP","og_description":"La DOG, la RG et le BVA mentionnent l'\u00e9lectrostimulation comme option dans la RP (directive 045\/23). Acc\u00e8s au texte de la directive et information sur l'\u00e9tude d'\u00e9valuation du G-BA.","og_url":"https:\/\/okuvision.de\/fr\/news\/leitlinie-rp\/","og_site_name":"Okuvision","article_published_time":"2024-10-07T13:45:28+00:00","article_modified_time":"2026-05-21T11:47:50+00:00","og_image":[{"width":2362,"height":1575,"url":"https:\/\/okuvision.de\/wp-content\/uploads\/2021\/10\/AdobeStock_1477380325_sw.png","type":"image\/png"}],"author":"Melanie Broll","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Melanie Broll","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/okuvision.de\/fr\/news\/leitlinie-rp\/#article","isPartOf":{"@id":"https:\/\/okuvision.de\/fr\/news\/leitlinie-rp\/"},"author":{"name":"Melanie Broll","@id":"https:\/\/okuvision.de\/fr\/#\/schema\/person\/8c5876ce322b1d535e693245db31cc1b"},"headline":"Directive 045\/23 : \u00c9lectrostimulation dans la RP","datePublished":"2024-10-07T13:45:28+00:00","dateModified":"2026-05-21T11:47:50+00:00","mainEntityOfPage":{"@id":"https:\/\/okuvision.de\/fr\/news\/leitlinie-rp\/"},"wordCount":373,"commentCount":0,"image":{"@id":"https:\/\/okuvision.de\/fr\/news\/leitlinie-rp\/#primaryimage"},"thumbnailUrl":"https:\/\/okuvision.de\/wp-content\/uploads\/2021\/10\/AdobeStock_1477380325_sw.png","articleSection":["Recherche et preuves","Entreprise & R\u00e9seau","Th\u00e9rapie et utilisation"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/okuvision.de\/fr\/news\/leitlinie-rp\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/okuvision.de\/fr\/news\/leitlinie-rp\/","url":"https:\/\/okuvision.de\/fr\/news\/leitlinie-rp\/","name":"Directive 045\/23 : \u00c9lectrostimulation recommand\u00e9e dans la RP","isPartOf":{"@id":"https:\/\/okuvision.de\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/okuvision.de\/fr\/news\/leitlinie-rp\/#primaryimage"},"image":{"@id":"https:\/\/okuvision.de\/fr\/news\/leitlinie-rp\/#primaryimage"},"thumbnailUrl":"https:\/\/okuvision.de\/wp-content\/uploads\/2021\/10\/AdobeStock_1477380325_sw.png","datePublished":"2024-10-07T13:45:28+00:00","dateModified":"2026-05-21T11:47:50+00:00","author":{"@id":"https:\/\/okuvision.de\/fr\/#\/schema\/person\/8c5876ce322b1d535e693245db31cc1b"},"description":"La DOG, la RG et le BVA mentionnent l'\u00e9lectrostimulation comme option dans la RP (directive 045\/23). Acc\u00e8s au texte de la directive et information sur l'\u00e9tude d'\u00e9valuation du G-BA.","breadcrumb":{"@id":"https:\/\/okuvision.de\/fr\/news\/leitlinie-rp\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/okuvision.de\/fr\/news\/leitlinie-rp\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/okuvision.de\/fr\/news\/leitlinie-rp\/#primaryimage","url":"https:\/\/okuvision.de\/wp-content\/uploads\/2021\/10\/AdobeStock_1477380325_sw.png","contentUrl":"https:\/\/okuvision.de\/wp-content\/uploads\/2021\/10\/AdobeStock_1477380325_sw.png","width":2362,"height":1575,"caption":"Okuvision: Arztgespr\u00e4ch\u00a0\u2013 H\u00e4nde von Patienten und Arzt auf dem Tisch"},{"@type":"BreadcrumbList","@id":"https:\/\/okuvision.de\/fr\/news\/leitlinie-rp\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/okuvision.de\/fr\/"},{"@type":"ListItem","position":2,"name":"Directive 045\/23 : \u00c9lectrostimulation dans la RP"}]},{"@type":"WebSite","@id":"https:\/\/okuvision.de\/fr\/#website","url":"https:\/\/okuvision.de\/fr\/","name":"Okuvision","description":"\u2013 Sehen erhalten","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/okuvision.de\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/okuvision.de\/fr\/#\/schema\/person\/8c5876ce322b1d535e693245db31cc1b","name":"Melanie Broll","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/ac571fa56fb7caf06fa0a3b99fbe83e949790cb8ce1b8cf70eba98e70e26bd7a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ac571fa56fb7caf06fa0a3b99fbe83e949790cb8ce1b8cf70eba98e70e26bd7a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ac571fa56fb7caf06fa0a3b99fbe83e949790cb8ce1b8cf70eba98e70e26bd7a?s=96&d=mm&r=g","caption":"Melanie Broll"},"url":"https:\/\/okuvision.de\/fr\/news\/author\/melanie-broll\/"}]}},"_links":{"self":[{"href":"https:\/\/okuvision.de\/fr\/wp-json\/wp\/v2\/posts\/2638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/okuvision.de\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/okuvision.de\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/okuvision.de\/fr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/okuvision.de\/fr\/wp-json\/wp\/v2\/comments?post=2638"}],"version-history":[{"count":5,"href":"https:\/\/okuvision.de\/fr\/wp-json\/wp\/v2\/posts\/2638\/revisions"}],"predecessor-version":[{"id":2684,"href":"https:\/\/okuvision.de\/fr\/wp-json\/wp\/v2\/posts\/2638\/revisions\/2684"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/okuvision.de\/fr\/wp-json\/wp\/v2\/media\/1569"}],"wp:attachment":[{"href":"https:\/\/okuvision.de\/fr\/wp-json\/wp\/v2\/media?parent=2638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/okuvision.de\/fr\/wp-json\/wp\/v2\/categories?post=2638"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/okuvision.de\/fr\/wp-json\/wp\/v2\/tags?post=2638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}